Recruiting NA INTERVENTIONAL 2-arm NCT04595929

Oncological Benefits of Pressured Intraperitoneal Aerosol Chemotherapy (PIPAC) in Patients With T3-4 Gastric Cancer Cyt- (GASPACCO)

Single-center Randomized Study Evaluating of Oncological Benifits of Pressured Intraperitoneal Aerosol Chemotherapy (PIPAC) in Patients With Locally Advanced Gastric Cancer in Patients With Cyt-.

Sponsor: St. Petersburg State Pavlov Medical University

Conditions Gastric Cancer Peritoneal Carcinomatosis

Interventions 5-Fluorouracil Adjuvant chemotherapy Docetaxel Leucovorin Oxaliplatin PIPAC Radical surgery Staging laparoscopy

Updated 6 times since 2020 Last updated: Nov 23, 2020 Started: Feb 10, 2020 Primary completion: Oct 10, 2021 Completion: Jan 10, 2029

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Gastric Cancer and Peritoneal Carcinomatosis, this trial is actively recruiting participants. The trial is conducted by St. Petersburg State Pavlov Medical University and has accumulated 6 data snapshots since 2020. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Recruiting NA
Sep 2024 — Sep 2025 [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Jan 2021 — Jul 2024 [monthly]

Recruiting NA
Dec 2020 — Jan 2021 [monthly]

Recruiting NA

▶ Show 1 earlier version

Nov 2020 — Dec 2020 [monthly]

Recruiting NA

First recorded

Feb 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

St. Petersburg State Pavlov Medical University

Data source: St. Petersburg State Pavlov Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Saint Petersburg, Russia